BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Returning digitally in 2021\, the 2nd Annual Gene Therapy for 
 Neurological Disorders Europe meeting will possibly be your last chance t
 o attend a European meeting without the airmiles!\n\nFocusing on the indu
 stry’s challenges of developing and delivering gene therapies to the CNS 
 and bringing fresh faces and emerging companies into the conversation\, t
 his is not one to miss as you seek to accelerate the development of your 
 neurological gene therapy.\n\nDiscover the latest neurological targets\, 
 familiarise yourself with the European landscape\, and debate and discuss
  with the leading minds of the field from the likes of UCB\, Lysogene\, U
 niQure and AskBio\, as they seek to harness the opportunity and move from
  rare to common disorders such as Alzheimer’s\, Parkinson’s and epilepsy.
 \n\nFocusing on translation and ‘what’s new’ in the gene therapy for neur
 ological disorders field\, this year’s 3-day agenda has been developed al
 ongside neurological experts from AskBio\, Handl Therapeutics\, Novartis 
 and Spark Therapeutics to capture the most pressing challenges and new op
 portunities facing the field.\n\nDiscussing rare to common neurological d
 isorders\, attend the digital meeting in July to:\n\nHear the latest clin
 ical updates from the most advanced companies to inform your future strat
 egiesDiscover the novel neurological targets being pursued by gene therap
 y developers to learn of the latest CNS opportunitiesDiscuss how to optim
 ize the use of preclinical models and biomarkers for improved translation
  and reduced risk to patientsAsk the European Medicines Agency questions 
 related to the specific regulatory challenges of designing trials for bot
 h rare and common disordersWeigh up the advantages and disadvantages of e
 stablished and novel routes of administration for CNS gene therapy delive
 ryRaise questions to the neurosurgeons at the forefront of neurosurgical 
 delivery and hear their thoughts on the technical challenges facing diffe
 rent programsBe a part of the debate and discussion related to measuring 
 and overcoming CNS immunogenic responses\n\nDon’t miss your opportunity t
 o benchmark against your competitors\, hear the state of the art technolo
 gy advances and research in the field\, and make new connections at the l
 ast digital European meeting\, to revolutionise the development and deliv
 ery of your neurological gene therapy.\n
DTEND:20210721T150000
DTSTAMP:20260512T232942Z
DTSTART:20210719T070000
LOCATION:Online\, \,
SEQUENCE:0
SUMMARY:Returning digitally in 2021\, the 2nd Annual Gene Therapy for Neur
 ological Disorders Europe meeting will possibly be your last chance to at
 tend a Eu...
UID:6db523cc-a8db-4c6c-98f9-0a05798bd556
END:VEVENT
END:VCALENDAR